Stanford Experts Explain Their Research
Stanford Medicine scientists have launched dozens of research projects as part of the global response to COVID-19. Some aim to prevent, diagnose and treat the disease; others aim to understand how it spreads and how people’s immune systems respond to it. Learn about the active COVID-19 research projects currently underway at Stanford Medicine.
August 21, 2020
Stanford researchers test oral COVID-19 treatment for mild cases
From The Stanford Daily
By Samantha Nichols
"A team of Stanford researchers have begun a clinical trial on Favipiravir, an antiviral drug that aims to reduce symptoms of COVID-19 and lower the risk of death for patients. The study, which began in July, is led by principal investigators Yvonne Maldonado and Chaitan Khosla. The medication comes in the form of a pill taken twice per day for 10 days and, if approved by the Food and Drug Administration (FDA), may become accessible for outpatient treatment of the novel coronavirus..." Read more »
May 7, 2020
Topics Discussed Include:
- Stanford Medicine is collaborating broadly across our entire university for COVID-19 research.
- We are working with UCSF and Chan Zuckerberg Biohub to provide policy makers with information on lifting the shelter-in-place.
- Stanford Health Care has started to safely resume elective surgical cases.
- Safety measures continue to include masking, PPE, and testing all employees for COVID-19.
- Updated data shows that 99.7% of our employees have tested negative for COVID-19, indicating that our infection control measures are effective and Stanford Health Care is safe.
May 14, 2020
Topics Discussed Include:
- Stanford University researchers speak on their efforts to study the COVID-19 pathogen.
- Discussion on the challenges of working with COVID-19.
- A brief overview of the history of pandemics.
- The immune response of COVID-19 infection in humans.
- How we can help accelerate the creation of a vaccine through crowdsourcing at eternagame.org.